Skip to Main Content

Author Details

Mathieu Hatt
INSERM
2006
121
43
PMIDPaper TitleJournal TitlePublished Year
37987783Multicentric development and evaluation of [<sup>18</sup>F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.Eur J Nucl Med Mol Imaging2024
36892667Multicentric development and evaluation of <sup>18</sup>F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer.Eur J Nucl Med Mol Imaging2023
37742374Automatic Head and Neck Tumor segmentation and outcome prediction relying on FDG-PET/CT images: Findings from the second edition of the HECKTOR challenge.Med Image Anal2023
36951992"Fuzzy" radiomics: the way forward for nuclear medicine imaging applications?Eur J Nucl Med Mol Imaging2023
37195050Overview of the HECKTOR Challenge at MICCAI 2022: Automatic Head and Neck Tumor Segmentation and Outcome Prediction in PET/CT.Head Neck Tumor Chall (2022)2023
36522184Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem.J Nucl Med2023
36690882Radiomics prognostic analysis of PET/CT images in a multicenter head and neck cancer cohort: investigating ComBat strategies, sub-volume characterization, and automatic segmentation.Eur J Nucl Med Mol Imaging2023
34255130The added value of PSMA PET/MR radiomics for prostate cancer staging.Eur J Nucl Med Mol Imaging2022
35618476Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines).J Nucl Med2022
35016077Head and neck tumor segmentation in PET/CT: The HECKTOR challenge.Med Image Anal2022
35205826External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.Cancers (Basel)2022
34632924Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images.Acta Oncol2022
34170367Prediction of recurrence after surgery in colorectal cancer patients using radiomics from diagnostic contrast-enhanced computed tomography: a two-center study.Eur Radiol2022
33380520Guidelines on Setting Up Stations for Remote Viewing of Nuclear Medicine and Molecular Imaging Studies During COVID-19.J Nucl Med Technol2021
33765601Artificial intelligence: Deep learning in oncological radiomics and challenges of interpretability and data harmonization.Phys Med2021
33652647Radiogenomics in Colorectal Cancer.Cancers (Basel)2021
33509369Radiomics in PET/CT: Current Status and Future AI-Based Evolutions.Semin Nucl Med2021
33918681Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer.Diagnostics (Basel)2021
33772335Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting.Eur J Nucl Med Mol Imaging2021
33772334[<sup>18</sup>F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.Eur J Nucl Med Mol Imaging2021
34733779Accurate Tumor Delineation <i>vs.</i> Rough Volume of Interest Analysis for <sup>18</sup>F-FDG PET/CT Radiomics-Based Prognostic Modeling inNon-Small Cell Lung Cancer.Front Oncol2021
34830828Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients.Cancers (Basel)2021
34016725Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, <sup>18</sup>F-FMISO PET, and <sup>18</sup>F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma.J Nucl Med2021
34064918Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer.J Pers Med2021
34037832Correction to: [<sup>18</sup>F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.Eur J Nucl Med Mol Imaging2021
34008178Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancers.Med Phys2021
34197503A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets.PLoS One2021
33197567Can alternative PET reconstruction schemes improve the prognostic value of radiomic features in non-small cell lung cancer?Methods2021
33161012Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer.Radiother Oncol2021
32221360Transcriptomics in cancer revealed by Positron Emission Tomography radiomics.Sci Rep2020
31732678Pretreatment <sup>18</sup>F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: A Multicentric Study.J Nucl Med2020
33137396Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures.Radiother Oncol2020
32861611[Radiation-oncology horizon 2030: From microbiota to plasma laser].Cancer Radiother2020
32688357Harmonization strategies for multicenter radiomics investigations.Phys Med Biol2020
32859468Use of radiomics in the radiation oncology setting: Where do we stand and what do we need?Cancer Radiother2020
32581221Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies.Sci Rep2020
32154773The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.Radiology2020
32457839Use of Baseline <sup><i>18</i></sup> F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer.Front Oncol2020
32231077External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer.Cancers (Basel)2020
30535746External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.Eur J Nucl Med Mol Imaging2019
30072293Potential Complementary Value of Noncontrast and Contrast Enhanced CT Radiomics in Colorectal Cancers.Acad Radiol2019
31474549Multicentric validation of radiomics findings: challenges and opportunities.EBioMedicine2019
31527580Machine learning for radiomics-based multimodality and multiparametric modeling.Q J Nucl Med Mol Imaging2019
31624321Revisiting the identification of tumor sub-volumes predictive of residual uptake after (chemo)radiotherapy: influence of segmentation methods on <sup>18</sup>F-FDG PET/CT images.Sci Rep2019
31481588Radiomics: Data Are Also Images.J Nucl Med2019
31280350Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications.Eur J Nucl Med Mol Imaging2019
31538516MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology.Br J Radiol2019
31508367MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer.Front Oncol2019
31278324Radiogenomics-based cancer prognosis in colorectal cancer.Sci Rep2019
30935573Reoxygenation during radiotherapy in intermediate-risk prostate cancer.Radiother Oncol2019
  • 1 - 50 of 121

Recommended Authors

Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 3
Carlos E Cardenas
The University of Texas MD Anderson Cancer Center
Career Start Year 2016
Number of shared co-authors 2
Ashirbani Saha
St. Michael's Hospital
Career Start Year 2015
Number of shared co-authors 0
Farzad Khalvati
Research Institute, The Hospital for Sick Children
Career Start Year 2013
Number of shared co-authors 0
Joshua D Schaefferkoetter
Siemens Medical Solutions USA, Inc.
Career Start Year 2013
Number of shared co-authors 2
Chuan Huang
The Renaissance School of Medicine at Stony Brook University
Career Start Year 2012
Number of shared co-authors 2
Peter Bandi
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center
Career Start Year 2011
Number of shared co-authors 1
Anahita Fathi Kazerooni
University of Pennsylvania.
Career Start Year 2011
Number of shared co-authors 2
Vincent Dunet
Lausanne University Hospital and University of Lausanne
Career Start Year 2011
Number of shared co-authors 0
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 1
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Career Start Year 2010
Number of shared co-authors 11
Zhifang Wu
The First Hospital of Shanxi Medical University
Career Start Year 2009
Number of shared co-authors 1
Jinzhong Yang
University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 3
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 11
Ramesh Paudyal
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Dan Ruan
Zhongshan Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 2
Lifei Zhang
The University of Texas MD Anderson Cancer Center.
Career Start Year 2006
Number of shared co-authors 1
Joost J C Verhoeff
University Medical Center Utrecht
Career Start Year 2005
Number of shared co-authors 3
Youngho Seo
University of California san francisco
Career Start Year 2005
Number of shared co-authors 2
Wouter van Elmpt
Maastricht University Medical Center+
Career Start Year 2005
Number of shared co-authors 18
Minsong Cao
University of California Los Angeles
Career Start Year 2005
Number of shared co-authors 0
Ahmed W Moawad
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Raymond Y Huang
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2002
Number of shared co-authors 3
Georges El Fakhri
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Career Start Year 1998
Number of shared co-authors 5
Amita Shukla-Dave
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Laurence E Court
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 1
Michael F McNitt-Gray
University of California los angeles
Career Start Year 1991
Number of shared co-authors 3
Magnus Dahlbom
David Geffen School of Medicine, university of california los angeles
Career Start Year 1988
Number of shared co-authors 4
Johannes Czernin
university of california los angeles
Career Start Year 1987
Number of shared co-authors 7

Collaborators

Philippe Lambin
Maastricht University
Co-authored papers 8
John A Lee
Institute of Experimental and Clinical Research
Co-authored papers 4
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 4
Arman Rahmim
BC Cancer Research Institute, University of British Columbia
Co-authored papers 4
Ir??ne Buvat
Institut Curie, PSL Research University, University Paris Saclay, Inserm LITO
Co-authored papers 3
Hesham Elhalawani
Co-authored papers 3
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers 3
Tyler J Bradshaw
University of Wisconsin-Madison
Co-authored papers 3
Ronald Boellaard
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 3
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Abhinav K Jha
Washington University in St. Louis
Co-authored papers 2
Johannes H A M Kaanders
Radboud University Medical Center
Co-authored papers 2
Sven Zuehlsdorff
Siemens Medical Solutions USA, Inc.
Co-authored papers 2
Babak Saboury
Clinical Center
Co-authored papers 2
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
John J Sunderland
University of Iowa
Co-authored papers 2
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 2
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 2
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Co-authored papers 2
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers 2
Matthieu Resche-Rigon
Universite Paris-Cite, INSERM
Co-authored papers 2
John L Humm
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Christos Davatzikos
University of Pennsylvania
Co-authored papers 1
Tristan Glatard
Concordia University
Co-authored papers 1
Quanzheng Li
Massachusetts General Hospital
Co-authored papers 1
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 1
Peter J H Scott
University of Michigan Medical School ann arbor
Co-authored papers 1
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 1
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Co-authored papers 1
Stephen B Solomon
Memorial Sloan-Kettering Cancer Center
Co-authored papers 1
Release 1.2